Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ortho Cyclen cardiovascular risk and insulin resistance in pre-menopausal women
NCT01475513Phase 4Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Nov 2011
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of norgestimate + ethinyl estradiol in contraception, sponsored by Virginia Commonwealth University. Started Nov 2011; status: completed.
02
Drugs
norgestimate + ethinyl estradiol
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01475513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01475513.